Glycostem is  invited to the second largest investor conference: the Jefferies Virtual Healthcare Conference on 4^th July. The interest in off-the-shelf NK-cells with no CRS issues is increasing rapidly.

Glycostem presents at ACCESS CHINA Online Partnering Day on 15^th May, 2020. ACCESS CHINA Partnering Day is the largest online corporate access event between China and Western Biopharma Industry. Glycostem is looking for investors and partnering opportunities.

On 14^th May Glycostem presents virtually a poster at ASGCT 2020 about oNKord^® “off-the-shelf” NK therapy closed system manufacturing process and clinical potential in AML, with a perspective on CAR-NK and other NK innovative therapies.

Glycostem participates in Bio CEO on 10^th and 11^th February 2020 in New York. Glycostem’s CEO Troels Jordansen provides an update on Glycostem.

Glycostem’s CEO Troels Jordansen provides an update on Glycostem at Phacilitate Leaders World & World Stem Cell Summit 2020 between 21^st and 24^th January 2020 in Miami.

Glycostem participates in BioTech Showcase from 13^th to 15^th January 2020 in San Francisco. Glycostem’s CEO Troels Jordansen is available for networking and partner discussions.